G1 Therapeutics, Inc.·4

Jun 12, 4:40 PM ET

RUDNICK SETH 4

4 · G1 Therapeutics, Inc. · Filed Jun 12, 2020

Insider Transaction Report

Form 4
Period: 2020-06-11
RUDNICK SETH
Director
Transactions
  • Award

    Stock Option (right to buy)

    2020-06-11+20,00020,000 total
    Exercise: $17.59Exp: 2030-06-11Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The shares underlying this option will vest in their entirety twelve months after June 11, 2020, subject to the Reporting Person's continued service as a director.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION